Market Place
Sourcing Support
Piramal Pharma Soars 13% on Heavy Volumes Post Q2 Report
06 Nov 2024 //
BUSINESS STD
Piramal Pharma Soars 25% in 6 Days on Strong Q2 Results
31 Oct 2024 //
BUSINESS STD
Piramal Pharma deploying USD 85 mn capex this fiscal
29 Oct 2024 //
ECONOMICTIMES
Piramal Pharma reports Q2 FY25 consolidated PAT at Rs. 22.59 Cr
25 Oct 2024 //
INDPHARMAPOST
Piramal Pharma Releases FY 2023-24 Sustainability Report
04 Oct 2024 //
PR NEWSWIRE
Piramal Pharma releases Sustainability Report FY 2023-24
04 Oct 2024 //
INDPHARMAPOST
Piramal to pump $80M into expansion of Kentucky injectables site
02 Oct 2024 //
FIERCE PHARMA
Piramal Pharma Solutions Announces US$ 80 Million Expansion Plan
01 Oct 2024 //
INDPHARMAPOST
Piramal Pharma wants to be a $2 billion global firm by 2030
25 Sep 2024 //
CNBCTV
Piramal Pharma’s GHG commitment validated and approved by SBTi
18 Sep 2024 //
EXPRESSPHARMA
Piramal Pharma`s GHG Commitment Validated and Approved by SBTi
16 Sep 2024 //
PR NEWSWIRE
Piramal Pharma Solutions Reaches Innovation Benchmark
30 Jul 2024 //
PRESS RELEASE
Piramal Pharma Announces Consolidated Results for Q1FY25
26 Jul 2024 //
PRESS RELEASE
Interview with Peter DeYoung, CEO, Piramal Pharma Solutions
21 May 2024 //
PRESS RELEASE
Piramal Pharma Limited Announces Results for Q4 and FY2024
11 May 2024 //
PRESS RELEASE
Piramal Pharma launches new campaign for `Polycrol` with Brand Ambassador
09 May 2024 //
INDINPHARMAPOST
Piramal Pharma forays into men`s grooming market in India launch of BOHEM
12 Apr 2024 //
INDIANPAHRAMPOST
Piramal Alternatives invests Rs 110 crore in Biodeal Pharmaceuticals
08 Apr 2024 //
ECONOMIC TIMES
Piramal Pharma`s Lexington facility gets two observations from USFDA
26 Feb 2024 //
BUSINESS STANDARD
Piramal API plant in Michigan hit with FDA Form 483 write-up
09 Feb 2024 //
FIERCE PHARMA
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024
30 Jan 2024 //
PRESS RELEASE
Piramal Pharma launches new concentration of Zinc Sulfate for Injection in U.S.
17 Jan 2024 //
INDIAN PHARMA POST
CDMO expands ADC facility in Scotland
21 Dec 2023 //
EUROPEAN PHARMACEUTICAL REVIEW
Piramal Commemorates Opening of Its Adc Manufacturing Expansion In Grangemouth
18 Dec 2023 //
PR NEWSWIRE
After a tough year, Piramal Pharma hopes to regain vigour in 2nd half
08 Nov 2023 //
ECONOMIC TIMES
Piramal Launches In-Vitro Biology Capabilities at Ahmedabad Services Site
17 Oct 2023 //
PR NEWSWIRE
Piramal Pharma`s US manufacturing unit successfully completes USFDA inspection
28 Sep 2023 //
CNBCTV18
Piramal Pharma Limited Announces Consolidated Results for Q1FY24
03 Aug 2023 //
PRESS RELEASE
Pickup in contract manufacturing biz set to drive growth: Piramal Pharma
01 Aug 2023 //
ECONOMIC TIMES
India resurgence fund in talks to acquire Ind-Swift`s API business
21 Jul 2023 //
ECONOMIC TIMES
SEBI approves Piramal Pharma’s Rs 1,050-crore rights issue
19 Jul 2023 //
INDIAN PHARMA POST
Piramal Pharma Limited Announces Consolidated Results for Q1FY24
24 May 2023 //
PRESS RELEASE
Meet the New Wave of Therapeutic Antibodies
11 May 2023 //
THE MEDICINE MAKER
Plus Therapeutics, Piramal Pharma Expand Partnership for cGMP Drug Production
05 May 2023 //
CONTRACT PHARMA
Piramal Supports Theracosbio With Integrated Drug Substance Program For Bexagliflozin
30 Mar 2023 //
PR NEWSWIRE
Piramal Announces Production of First Batches at New API Facility In Riverview
16 Feb 2023 //
PR NEWSWIRE
Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023
08 Feb 2023 //
PR NEWSWIRE
USFDA issues Form-483 with two observations to Piramal`s Sellersville unit
18 Jan 2023 //
CNBCTV18
Piramal Pharma slips as US FDA issues Form 483 with six observations
11 Jan 2023 //
BUSINESS-STANDARD
Verrica Announces Transfer of Bulk Solution Manufacturing of VP-102 to Piramal
04 Jan 2023 //
GLOBENEWSWIRE
Peter DeYoung CEO Global Pharma - Piramal Pharma Limited
14 Dec 2022 //
INVESTMENT REPORTS
Piramal Pharma plunges 48% since listing on selling pressure
19 Nov 2022 //
ECONOMICTIMES
Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023
08 Nov 2022 //
PRESS RELEASE
Piramal Announces Winner of its 2022 Award for Excellence in Patient Centricity
02 Nov 2022 //
PRESS RELEASE
Piramal Pharma Lists on Stock Exchanges Following Demerger
20 Oct 2022 //
CONTRACTPHARMA
Yapan Bio Adds New Process Development Facility
18 Oct 2022 //
PRESS RELEASE
Piramal Pharma unveils its Sustainability Report FY21-22
13 Oct 2022 //
PRNEWSWIRE
Piramal Pharma Solutions Launches ADCelerate, a Rapid, Integrated Approach to Taking ADCs to IND
13 Oct 2022 //
PRNEWSWIRE
Piramal Pharma Appoints Vibha Paul Rishi as Non- Executive Director to its Board of Directors
30 Sep 2022 //
PR NEWSWIRE
Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
19 Aug 2022 //
PRNEWSWIRE
Piramal Enterprises gets NCLT nod for demerger
13 Aug 2022 //
FINACIAL EXPRESS
Piramal Holds Grand Opening Ceremony for New API Plant at Aurora, Canada
12 Jul 2022 //
PRNEWSWIRE
Pharma business with strong quality compliance to emerge stronger: Ajay Piramal
08 Jul 2022 //
ECONOMIC TIMES
Piramal Pharma Ltd Strengthens Board by Inducting Three New Board Members
08 Jul 2022 //
PRNEWSWIRE
Piramal Enterprises gets shareholders’ nod for demerger
07 Jul 2022 //
FINANCIALEXPRESS
Piramal Pharma Limited’s Consumer Products Division unveils a new campaign
01 Jul 2022 //
FINANCIALEXPRESS
Piramal Pharma Solutions Appoints Herve Berdou as Chief Operating Officer
22 Jun 2022 //
PRNEWSWIRE
GBR Connect Series - Interview with Peter DeYoung, Piramal Pharma Solutions
22 Jun 2022 //
GBREPORTS
Piramal Pharma Solutions Expands API Capabilities in India
15 Jun 2022 //
CONTRACT PHARMA
Piramal Pharma Solutions Retains No 1 Position In Indian Bioservices Industry
01 Jun 2022 //
PRESS RELEASE
